Skip to main content
. 2020 May 20;45(1):247–257. doi: 10.1038/s41366-020-0596-5

Table 2.

Factors showing significant or borderline significant association with placental inositol.

Categorical variable Unadjusted β (95% CI) placental inositol z-score (SDs) P value Adjusted β (95% CI)a placental inositol z-score (SDs) P value
Tobacco smoke exposure
 No Reference Reference
 Yes 0.22 (0.08, 0.36) 0.002 0.24 (0.08, 0.40) 0.003
Mode of delivery
 Non-labour caesarean section Reference Reference
 Intrapartum caesarean section −0.11 (−0.36, 0.14) 0.388 −0.15 (−0.44, 1.35) 0.299
 Vaginal delivery −0.21 (−0.41, −0.14) 0.036 −0.29 (−0.52, −0.06) 0.013
Timing of placental collection after delivery (minutes)
 ≤30 Reference Reference
 31–60 −0.18 (−0.39, 0.03) 0.094 −0.18 (−0.41, 0.05) 0.133
 61–90 −0.30 (−0.54, −0.06) 0.013 −0.29 (−0.55, −0.02) 0.033
 ≥91 −0.35 (−0.63, −0.07) 0.013 −0.22 (−0.53, 0.08) 0.148
Continuous variable Unadjusted β (95% CI) Placental inositol SDs/unit increase P value Adjusted β (95% CI)a Placental inositol SDs/unit increase P value
2hPG (mmol/L) −0.05 (−0.10, −0.01) 0.021 −0.06 (−0.12, −0.01) 0.028
Gestational age at birth (days) 0.01 (0, 0.02) 0.026 0.01 (0, 0.03) 0.008

2hPG 2-hour plasma glucose.

aAdjusted for maternal age, ethnicity, parity, pre-pregnancy BMI, neonatal sex, and mutually adjusted for tobacco smoke exposure, gestational age, mode of delivery, timing of placental collection after delivery, and 2hPG at mid-gestation.